Remote monitoring: Doomed to let down or an attractive promise?. (September 2019)

• Record Type: Journal Article
• Authors: Lucà, Fabiana; Cipolletta, Laura; Di Fusco, Stefania Angela; Iorio, Annamaria; Pozzi, Andrea; Rao, Carmelo Massimiliano; Ingianni, Nadia; Benvenuto, Manuela; Madeo, Andrea; Fiscella, Damiana; Benedetto, Daniela; Francese, Giuseppina Maura; Gelsomino, Sandro; Zecchin, Massimo; Gabrielli, Domenico; Gulizia, Michele Massimo
• Is Part Of: IJC heart & vasculature. Volume 24(2019)
• Publication Date: 2019-09
• Subjects: AHRE Atrial High Rate Episodes -- ARTESIA Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation -- ASSERT ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and atrial fibrillation Reduction atrial pacing Trial -- CHAMPION CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients -- CIED Cardiac Implantable Electronic Devices -- CONNECT Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision -- COMPAS COMPArative follow-up Schedule with home monitoring -- CRT Cardiac Resynchronization Therapy -- EVOLVO Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators -- ECOST Effectiveness and Cost of ICDs Follow-up Schedule with Telecardiology -- EHRA European Heart Rhythm Association -- ICD Implantable Cardioverter Defibrillator -- IMPACT Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk -- IN-TIME Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function -- ISHNE International Society for Holter and Noninvasive Electrocardiology -- MoniC Model Project Monitor Centre -- MORE-CARE MOnitoring Resynchronization dEvices and CARdiac patiEnts -- MULTISENSE HF Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients -- NOAH Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes -- NYHA New York Heart Association -- OPTILINK-HF Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink Network -- PMK Pacemaker -- PARTNERS HF Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure -- RM Remote Monitoring -- REFORM Trial Remote Follow-Up for ICD-Therapy in Patients Meeting MADIT II Criteria -- RM-HF REmote Monitoring: an evaluation of implantable devices for management of Heart Failure patients -- SELENE Selection of potential predictors of worsening Heart Failure -- TARIFF Evaluation Registry for Remote Follow-up -- TRUST Lumos-T Safely Reduces Routine Office Device Follow-up; Implantable devices -- Heart failure -- Atrial fibrillation -- Remote telemonitoring; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Pathophysiology -- Periodicals; 616.1005
• DOI: 10.1016/j.ijcha.2019.100380
• Languages: English
• ISSNs: 2352-9067

Abstract

Abstract: Device interrogation and management are time consuming, representing a relevant burden for pacing centers. In several situations, patients' management requires additional follow up visits. Remote Monitoring (RM) allows an optimal recall management and a rapid diagnosis of device or lead failure, without the need of additional in office visits. Further it allows a significant delay reduction between the adverse event and the reaction to the alarm, shortening the time needed to make a clinical decision. A role in risk-predicting patient-related outcomes has also been shown. RM permits detection of the arrhythmia from 1 to 5 months in advance compared to in-office visits. Importantly, by using specific algorithms with multiparametric analysis, RM has been studied as a potential instrument to identify early patients on risk of worsening HF using specific algorithms. Although the use of RM in HF setting remains controversial, it has been proposed to improve HF clinical outcomes and survival in clinical trials. In this sense, RM success could require a standardization of process within a management model, that may involve different health care professionals. In this review, we examine recent advances of RM providing an update of this tool through different clinical scenarios.